HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anxiety secondary to depression.

Abstract
Studies of familial transmission, twin concordance, epidemiologic patterns, and diagnostic stability on follow-up all support the fundamental separation of affective and anxiety disorders. The importance of subdividing cosyndromal conditions by the presumed primary illness follows logically from these data, and convention suggests the use of temporal sequencing to do this; however, evidence that this approach is successful is modest. At a practical level, panic attacks seem to indicate a depression of greater severity and poorer overall prognosis. Moreover, obsessions and compulsions that develop within depressive episodes tend to differ in their themes from those that develop autonomously, and depression may precipitate only certain types of phobias. Finally, panic attacks may predict better responses to MAOIs and poorer responses to conventional tricyclic antidepressants. All of these conclusions are based on a relatively small amount of literature. Interest in this topic has grown rapidly in the past decade, and subsequent reviews will draw different, or at least additional conclusions.
AuthorsW Coryell
JournalThe Psychiatric clinics of North America (Psychiatr Clin North Am) Vol. 13 Issue 4 Pg. 685-98 (Dec 1990) ISSN: 0193-953X [Print] United States
PMID2281013 (Publication Type: Journal Article, Review)
Chemical References
  • Antidepressive Agents, Tricyclic
  • Monoamine Oxidase Inhibitors
Topics
  • Antidepressive Agents, Tricyclic (therapeutic use)
  • Anxiety Disorders (diagnosis, drug therapy, psychology)
  • Depressive Disorder (diagnosis, drug therapy, psychology)
  • Humans
  • Monoamine Oxidase Inhibitors (therapeutic use)
  • Panic (drug effects)
  • Recurrence
  • Syndrome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: